Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM50142189 (CHEMBL3759239 | US10329256, Example 5 | US9487512,...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 50 | -43.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256459 (US10329256, Example 3 | US9487512, 3 | US9944601, ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | 50 | -43.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256457 (US9487512, 1) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 50 | -43.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256460 (US9487512, 4) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 50 | -43.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256461 (US10329256, Example 6 | US9487512, 6 | US9944601, ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 50 | -43.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256458 (US10329256, Example 2 | US9487512, 2 | US9944601, ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 550 | -37.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256462 (US10329256, Example 7 | US9487512, 7 | US9944601, ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | -37.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256464 (US10329256, Example 9 | US9487512, 9 | US9944601, ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | -37.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256463 (US10329256, Example 8 | US9487512, 8 | US9944601, ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.50E+3 | -31.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256462 (US10329256, Example 7 | US9487512, 7 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.50E+3 | -31.2 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256464 (US10329256, Example 9 | US9487512, 9 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.50E+3 | -31.2 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256460 (US9487512, 4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.50E+3 | -31.2 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256463 (US10329256, Example 8 | US9487512, 8 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.50E+4 | -25.3 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256461 (US10329256, Example 6 | US9487512, 6 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.50E+4 | -25.3 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256464 (US10329256, Example 9 | US9487512, 9 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.50E+4 | -25.3 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256462 (US10329256, Example 7 | US9487512, 7 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.50E+4 | -25.3 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256461 (US10329256, Example 6 | US9487512, 6 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.50E+4 | -25.3 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256463 (US10329256, Example 8 | US9487512, 8 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.50E+4 | -25.3 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256460 (US9487512, 4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.50E+4 | -25.3 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM50142189 (CHEMBL3759239 | US10329256, Example 5 | US9487512,...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 5.50E+4 | -25.3 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256458 (US10329256, Example 2 | US9487512, 2 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | >1.00E+5 | >-23.7 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256457 (US9487512, 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | >1.00E+5 | >-23.7 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM50142189 (CHEMBL3759239 | US10329256, Example 5 | US9487512,...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | >1.00E+5 | >-23.7 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256459 (US10329256, Example 3 | US9487512, 3 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | >1.00E+5 | >-23.7 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256458 (US10329256, Example 2 | US9487512, 2 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | >1.00E+5 | >-23.7 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256457 (US9487512, 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | >1.00E+5 | >-23.7 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256459 (US10329256, Example 3 | US9487512, 3 | US9944601, ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | >1.00E+5 | >-23.7 | n/a | n/a | n/a | n/a | n/a | 7.5 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256482 (US10329256, Example 27 | US9487512, 27 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256460 (US9487512, 4) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM50142189 (CHEMBL3759239 | US10329256, Example 5 | US9487512,...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256484 (US10329256, Example 29 | US9487512, 29 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256498 (US10329256, Example 43 | US9487512, 43 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256481 (US10329256, Example 26 | US9487512, 26 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256497 (US10329256, Example 42 | US9487512, 42 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 37 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256475 (US10329256, Example 20 | US9487512, 20 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256461 (US10329256, Example 6 | US9487512, 6 | US9944601, ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256486 (US10329256, Example 31 | US9487512, 31 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256459 (US10329256, Example 3 | US9487512, 3 | US9944601, ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256479 (US10329256, Example 24 | US9487512, 24 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 47 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256470 (US10329256, Example 15 | US9487512, 15 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 48 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256457 (US9487512, 1) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256491 (US10329256, Example 36 | US9487512, 36 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 68 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256468 (US10329256, Example 13 | US9487512, 13 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 69 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256469 (US10329256, Example 14 | US9487512, 14 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 71 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256499 (US10329256, Example 44 | US9487512, 44 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 72 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256473 (US10329256, Example 18 | US9487512, 18 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 81 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256483 (US10329256, Example 28 | US9487512, 28 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 84 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256480 (US10329256, Example 25 | US9487512, 25 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 97 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256489 (US10329256, Example 34 | US9487512, 34 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 104 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Isoform 2 of Lysine-specific histone demethylase 1A (2) [158-876] (Homo sapiens (Human)) | BDBM256474 (US10329256, Example 19 | US9487512, 19 | US9944601...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 105 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Oryzon Genomics S.A. US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US9487512 (2016) BindingDB Entry DOI: 10.7270/Q2765D89 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 159 total ) | Next | Last >> |